Literature DB >> 22409321

In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates.

Filip Boyen1, Koen M H W Verstappen, Manuelle De Bock, Birgitta Duim, J Scott Weese, Stefan Schwarz, Freddy Haesebrouck, Jaap A Wagenaar.   

Abstract

BACKGROUND: Meticillin-resistant Staphylococcus aureus (MRSA) and meticillin-resistant Staphylococcus pseudintermedius (MRSP) infections are increasingly reported in dogs, and these bacteria may be isolated from ear infections. HYPOTHESIS/
OBJECTIVES: The main aim of the present study was to investigate the in vitro antimicrobial activity of miconazole, polymyxin B and a combination of both against 24 canine MRSA and 50 canine MRSP isolates. The minimal inhibitory concentration (MIC) values of 12 other antimicrobial agents were also determined.
METHODS: All MIC values were determined according to a broth microdilution assay.
RESULTS: Acquired resistance was found to all tested agents, except for linezolid, miconazole and polymyxin B. The MIC values for miconazole and polymyxin B against MRSA were in the range of 4-8 and 8-64 μg/mL, respectively, while the MIC values for miconazole and polymyxin B against MRSP were in the range of 1-2 and 0.25-4 μg/mL, respectively. Using a combination of miconazole and polymyxin B, there was no evidence for enhanced in vitro activity of the combination (i.e. synergy) of both products. Nevertheless, MIC(90) values of the combination of these antimicrobial agents and of a commercial product containing both agents were at least 1000 times lower than the concentration present in the commercial product. CONCLUSIONS AND CLINICAL IMPORTANCE: These results indicate that the topical use of a combination of miconazole and polymyxin B in a 43.5:1 ratio may have potential for the treatment of MRSA-mediated and MRSP-associated otitis externa in dogs.
© 2012 The Authors. Veterinary Dermatology © 2012 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409321     DOI: 10.1111/j.1365-3164.2012.01040.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  7 in total

1.  Hydrophobic interactions modulate antimicrobial peptoid selectivity towards anionic lipid membranes.

Authors:  Konstantin Andreev; Michael W Martynowycz; Mia L Huang; Ivan Kuzmenko; Wei Bu; Kent Kirshenbaum; David Gidalevitz
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-03       Impact factor: 3.747

2.  Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions.

Authors:  Ryan Kean; Ranjith Rajendran; Jennifer Haggarty; Eleanor M Townsend; Bryn Short; Karl E Burgess; Sue Lang; Owain Millington; William G Mackay; Craig Williams; Gordon Ramage
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

3.  Prevalence and antimicrobial drug resistance of Staphylococcus aureus isolated from cow milk samples.

Authors:  Matlale Phriskey Mphahlele; James Wabwire Oguttu; Inge-Marie Petzer; Daniel Nenene Qekwana
Journal:  Vet World       Date:  2020-12-21

4.  Synthesis, Spectroscopy, Single-Crystal Structure Analysis and Antibacterial Activity of Two Novel Complexes of Silver(I) with Miconazole Drug.

Authors:  Karolina Stryjska; Izabela Korona-Glowniak; Lilianna Chęcińska; Joachim Kusz; Justyn Ochocki
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

5.  Multiple Antimicrobial Effects of Hybrid Peptides Synthesized Based on the Sequence of Ribosomal S1 Protein from Staphylococcus aureus.

Authors:  Sergey V Kravchenko; Pavel A Domnin; Sergei Y Grishin; Alexander V Panfilov; Viacheslav N Azev; Leila G Mustaeva; Elena Y Gorbunova; Margarita I Kobyakova; Alexey K Surin; Anna V Glyakina; Roman S Fadeev; Svetlana A Ermolaeva; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

6.  Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.

Authors:  Piotr Szweda; Marta Schielmann; Aneta Frankowska; Barbara Kot; Magdalena Zalewska
Journal:  J Vet Med Sci       Date:  2013-11-11       Impact factor: 1.267

7.  The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.

Authors:  Silvia Pietschmann; Michael Meyer; Michael Voget; Michael Cieslicki
Journal:  Vet Dermatol       Date:  2013-05-31       Impact factor: 1.589

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.